Medicare

Commentary

Competing To Save The Health-Care System Money

American seniors recently received some good news — they won’t be seeing higher premiums in 2012 for their Medicare prescription drug benefits. In fact, the rates they pay for prescription drug coverage under Medicare Part D will decline this coming year, according to the U.S. Department of Health and Human ...
Business & Economics

The Federal War Against Medical Technology

At about $75 billion annually, U.S. private-sector investment in medical technology is substantial, and a large body of research demonstrates that the economic returns to these investments are enormous. But emerging federal policies are likely to create powerful disincentives for the research and development of medical innovations, in particular, pharmaceuticals ...
Commentary

Counting Up ObamaCare’s Health Cost Inflation

It’s time to add yet another study to the growing list of research showing that ObamaCare isn’t delivering on its grand promises. In the July issue of the journal Health Affairs, Medicare’s actuaries released new estimates of the rate of growth of national health costs. Surprise, surprise — they’re projected ...
Commentary

Senior Citizens Will Pay Dearly For Health Care Price Controls

Squabbles over spending cuts have ruled the negotiations over increasing the debt ceiling. But even after the ink is dry on the budget deal just passed, lawmakers will still be charged with reducing federal spending further. One proposal that refuses to die would impose price controls on prescription drugs in ...
Commentary

Congress Should Apply Clinton-era Reform to Medicare

A successful welfare reform from the 1990s offers a model to reform a currently out-of-control program many Americans assume to be an entitlement, but which is actually welfare. The program is Medicaid, which should be easier to fix, politically, than the so-called entitlements of Social Security and Medicare. The politicians ...
Commentary

Path Dependency in Medicare Reform

Arguments will not change this fact: People change when the pain of not changing becomes greater than the pain of changing, but not before. This can be the only explanation for the majority of respondents to polls (described here) which ask the foolish question whether “Medicare should remain as it ...
Commentary

Grim Reality of Medicare Reform

Sure, I’ll admit I had the urge to jump up and down and pump my fists in the air. But then I read Henry Olsen’s warning about alienating blue-collar voters, and I decided that while McCarthy’s scorched-earth approach may be the right one for the conservative patriot to adopt when ...
Business & Economics

Medicare Auctions for Durable Medical Equipment: Price Suppression and Research and Development Investment

San Francisco (June 13, 2011)—A new research study released by the Pacific Research Institute (PRI), a California-based free-market think tank, reviews the auction design process currently established by the Centers for Medicare and Medicaid Services (CMS) for medical devices and equipment. That process creates important adverse economic effects: It yields ...
Commentary

Mission Impossible: Medicare’s Independent Payment Advisory Board

Key Points • The Independent Payment Advisory Board (IPAB) is a new bureaucracy established by Obamacare that will limit Medicare beneficiaries’ access to certain medical goods and services—especially new prescription drugs. • IPAB puts Medicare beneficiaries’ access to prescription drugs and certain other medical goods and services under control of ...
Health Care

The Ryan Republican Medicare Reforms: What They Are, What They’re Not, and What They Might Become

Key Points The Medicare part of the Ryan budget is superior to Obamacare but needs more definition. The current proposal would limit future Medicare beneficiaries’ choices to those selected from a federal exchange. Medicare beneficiaries would benefit more from Republicans’ clear commitment to restore Medicare Advantage, a popular alternative to ...
Commentary

Competing To Save The Health-Care System Money

American seniors recently received some good news — they won’t be seeing higher premiums in 2012 for their Medicare prescription drug benefits. In fact, the rates they pay for prescription drug coverage under Medicare Part D will decline this coming year, according to the U.S. Department of Health and Human ...
Business & Economics

The Federal War Against Medical Technology

At about $75 billion annually, U.S. private-sector investment in medical technology is substantial, and a large body of research demonstrates that the economic returns to these investments are enormous. But emerging federal policies are likely to create powerful disincentives for the research and development of medical innovations, in particular, pharmaceuticals ...
Commentary

Counting Up ObamaCare’s Health Cost Inflation

It’s time to add yet another study to the growing list of research showing that ObamaCare isn’t delivering on its grand promises. In the July issue of the journal Health Affairs, Medicare’s actuaries released new estimates of the rate of growth of national health costs. Surprise, surprise — they’re projected ...
Commentary

Senior Citizens Will Pay Dearly For Health Care Price Controls

Squabbles over spending cuts have ruled the negotiations over increasing the debt ceiling. But even after the ink is dry on the budget deal just passed, lawmakers will still be charged with reducing federal spending further. One proposal that refuses to die would impose price controls on prescription drugs in ...
Commentary

Congress Should Apply Clinton-era Reform to Medicare

A successful welfare reform from the 1990s offers a model to reform a currently out-of-control program many Americans assume to be an entitlement, but which is actually welfare. The program is Medicaid, which should be easier to fix, politically, than the so-called entitlements of Social Security and Medicare. The politicians ...
Commentary

Path Dependency in Medicare Reform

Arguments will not change this fact: People change when the pain of not changing becomes greater than the pain of changing, but not before. This can be the only explanation for the majority of respondents to polls (described here) which ask the foolish question whether “Medicare should remain as it ...
Commentary

Grim Reality of Medicare Reform

Sure, I’ll admit I had the urge to jump up and down and pump my fists in the air. But then I read Henry Olsen’s warning about alienating blue-collar voters, and I decided that while McCarthy’s scorched-earth approach may be the right one for the conservative patriot to adopt when ...
Business & Economics

Medicare Auctions for Durable Medical Equipment: Price Suppression and Research and Development Investment

San Francisco (June 13, 2011)—A new research study released by the Pacific Research Institute (PRI), a California-based free-market think tank, reviews the auction design process currently established by the Centers for Medicare and Medicaid Services (CMS) for medical devices and equipment. That process creates important adverse economic effects: It yields ...
Commentary

Mission Impossible: Medicare’s Independent Payment Advisory Board

Key Points • The Independent Payment Advisory Board (IPAB) is a new bureaucracy established by Obamacare that will limit Medicare beneficiaries’ access to certain medical goods and services—especially new prescription drugs. • IPAB puts Medicare beneficiaries’ access to prescription drugs and certain other medical goods and services under control of ...
Health Care

The Ryan Republican Medicare Reforms: What They Are, What They’re Not, and What They Might Become

Key Points The Medicare part of the Ryan budget is superior to Obamacare but needs more definition. The current proposal would limit future Medicare beneficiaries’ choices to those selected from a federal exchange. Medicare beneficiaries would benefit more from Republicans’ clear commitment to restore Medicare Advantage, a popular alternative to ...
Scroll to Top